Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410252 · ClinicalTrials.gov registry record · NA
Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02410252: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02410252 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02410252, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the use feasibility of the iThermonitor, a continuous temperature monitoring device, as a clinical support and patient self-management tool in the management of pediatrics patients on myelosuppressive therapies for acute leukemia and other childhood cancers.
Interventions
- DEVICE iThermonitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410252
The ClinicalTrials.gov registry entry for NCT02410252 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iThermonitor is the first listed.
NCT02410252 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02410252 about?
NCT02410252 is a clinical study titled "Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies". This is a pilot study to evaluate the use feasibility of the iThermonitor, a continuous temperature monitoring device, as a clinical support and patient self-management tool in the management of pediatrics patients on myelosuppressive therapies for acute leukemia and other childhood cancers.
What is the current status of trial NCT02410252?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2015-05. Estimated completion is 2017-08.
What interventions are being tested in trial NCT02410252?
The interventions under investigation include: iThermonitor (DEVICE).
Who is sponsoring clinical trial NCT02410252?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.